comparemela.com

Latest Breaking News On - Simmons comprehensive cancer center - Page 4 : comparemela.com

As More Survive Cancer, Issues With Sleep, Fatigue, Cognitive Function on the Rise

The April 2 plenary session at the National Comprehensive Cancer Network (NCCN) 2023 Annual Conference, entitled, “Sleep Disorders, Fatigue, and Cognitive Function in Cancer Survivors" reviewed guidelines for handling symptoms that are increasingly common as the survivorship ranks grow.

United statesHallecf mooreErics zhouJennifer schmitzKristin dickinsonAmerican college of physiciansDana farber cancer instituteUt southwestern simmons comprehensive cancer centerNational cancer instituteInternational classification of sleep disordersFred pamela buffett cancer centerNational comprehensive cancer networkAmerican college of sports medicineCleveland clinic taussig cancer instituteHarvard medical schoolAmerican association of sleep medicine

$20 Million in CPRIT Cancer Research Funds Heading to North Texas

UT Dallas received $6 million to recruit an established researcher from the University of Rochester.

United statesEl pasoSan antonioUniversity of texasSamuel mcbreyerLance teradaDavid gerberWayne robertsKeith argenbrightCarlos arteagaRodney infanteTao wangGuanghua xiaoZhenyu zhongRam maniLisak simmons

Oral SERD Camizestrant Prolongs PFS vs Fulvestrant in Breast Cancer

"The results of SERENA-2 support further development of camizestrant in ER-positive breast cancer."

France generalSan antonioUnited statesComunidad autonoma de catalunaFabrice andreCarlos artegaDaiichi sankyoGustave roussyMafalda oliveiraGuardant healthHebron university hospitalSimmons comprehensive cancer centerMedscape professional networkUt southwestern medical centerSan antonio breast cancerMedical center

Antibody Drug Boosts Survival for Type of Advanced Breast Cancer

THURSDAY, Dec. 8, 2022 (HealthDay News) A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven t responded to other

United statesSan antonioSara hurvitzLos angelesIan kropCarlos arteagaGeffen school of medicineUniversity of californiaUt southwestern medical centerYale cancer centerDrug administrationJonsson comprehensive cancer centerSimmons comprehensive cancer centerHealthday newsSan antonio breast cancerMedical center

T-DXd Continues Winning Streak in Metastatic, HER2-Positive Breast Cancer

Trastuzumab deruxtecan improves survival in second- and later-line settings

United statesNew havenSan antonioIan kropSaraa hurvitzCarlos arteagaUniversity of california los angelesYale cancer centerSimmons comprehensive cancer centerSan antonio breast cancerCalifornia losCan be caughtAntonio breast cancer

vimarsana © 2020. All Rights Reserved.